Drug Type Small molecule drug |
Synonyms 比沙可啶/熊去氧胆酸/二辛基磺化琥珀酸钠 |
Target |
Mechanism FXR antagonists(Bile acid receptor FXR antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (26 Aug 2024), |
Regulation- |
Molecular FormulaC20H38O7S |
InChIKeyHNSDLXPSAYFUHK-UHFFFAOYSA-N |
CAS Registry10041-19-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Constipation | KR | 26 Aug 2024 |